Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). 23andMe Holding Co's share price for the quarter that ended in Dec. 2023 was $0.9135. 23andMe Holding Co's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 482.6 Mil. Therefore, 23andMe Holding Co's market cap for the quarter that ended in Dec. 2023 was $440.8 Mil.
23andMe Holding Co's quarterly market cap
declined
from Jun. 2023 ($826.2 Mil) to Sep. 2023 ($468.2 Mil) and
declined
from Sep. 2023 ($468.2 Mil) to Dec. 2023 ($440.8 Mil).
23andMe Holding Co's annual market cap
increased
from Mar. 2021 ($0.0 Mil) to Mar. 2022 ($1,718.9 Mil) but then
declined
from Mar. 2022 ($1,718.9 Mil) to Mar. 2023 ($1,051.5 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. 23andMe Holding Co's Enterprise Value for Today is $60.5 Mil.
23andMe Holding Co Market Cap Historical Data
The historical data trend for 23andMe Holding Co's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of 23andMe Holding Co's Market Cap
For the Diagnostics & Research subindustry, 23andMe Holding Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
23andMe Holding Co's Market Cap Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, 23andMe Holding Co's Market Cap distribution charts can be found below:
* The bar in red indicates where 23andMe Holding Co's Market Cap falls into.
23andMe Holding Co Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
23andMe Holding Co's Market Cap for the fiscal year that ended in Mar. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
23andMe Holding Co (NAS:ME) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
23andMe Holding Co Market Cap Related Terms
Thank you for viewing the detailed overview of 23andMe Holding Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
23andMe Holding Co (23andMe Holding Co) Business Description
23andMe Holding Co is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. Its segment include Consumer and Research Services and Therapeutics. The company generates maximum revenue from the Consumer and Research Services segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ME has been successfully added to your 